Key result
Rare athlete sudden cardiac death rates challenge proven pre-participation screening efficacy and cost-effectiveness.
Why the study?
Sudden cardiac death in athletes is a rare but highly visible event that motivates screening despite challenges in proving screening efficacy and cost-effectiveness.
Population
5 million active athletes at high school, university, professional, and master’s levels in the United States
Design
Review article
Authors
Loading...
Rarity of SCD limits screening value evidence; leaves open targeted protocols and large trials before practice change.
Michael H. Crawford (2007) conducted a review in Heart disease and sudden cardiac death. Pre-participation screening was evaluated. Sudden cardiac death is a rare event among athletes (e.g., 1:100,000-200,000 in high school athletes), making the efficacy and cost-effectiveness of pre-participation screening challenging to prove.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: